While CAR-T cell therapies have emerged as a promising alternative for treating B-cell leukemias and lymphomas, their ...

In a significant advancement in cancer treatment, a team of Brazilian researchers has engineered a groundbreaking CAR-T cell ...

Adoptive Cell Transfer (ACT) includes a class of immunotherapy approaches to treat cancer.  This procedure focuses on a ...

Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep ...

At the 151st Kentucky Derby, a global spotlight will shine on equine athleticism. It’s the subject of a growing body of ...

NICE has approved Novartis’ CAR-T therapy Kymriah (tisagenlecleucel) for diffuse large B-cell lymphoma (DLBCL) in adults who did not respond to two or more previous treatments. The drug will be ...

It includes your lymph nodes, bone marrow, spleen, and thymus ... sample of bone marrow to check for lymphoma cells. A bone marrow biopsy isn’t necessary for everyone with a lymphoma diagnosis.

Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated ... with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large ...

This innate immune activation underscores the potential of IFx-Hu2.0 to generate tumor specific activate T and B cells for patients who are resistant to anti-PD-1 CPIs. Additionally, IFx-Hu2.0 was ...

Thymic involution and inflammation are both related to age-associated immunity. T & B cells in aging The pool of naive cells is reduced, while effector memory and potentially dysfunctional late ...